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1. Introduction 
Systemic autoimmune diseases, such as systemic lupus erythematosus (lupus, SLE), 
rheumatoid arthritis and systemic sclerosis (scleroderma), occur in up to 5-8% of the human 
population. Based on frequency of occurrence, they are the third most common diseases 
after cardiovascular pathologies and cancers. The overwhelming majority of cases of 
autoimmune diseases are in women (Fairweather & Rose, 2004). 
Nowadays, great attention is paid to studying the impact of environment on the 
development of autoimmunity and autoimmune diseases. This is due to the increased 
influence of anthropogenic factors on the quality of human life. There is a good reason to 
suppose that repeated exposure of people to low doses of heavy metal compounds may 
promote the development of such diseases (Havarinasab et al., 2009). Humans can be 
exposed to these noxious substances from atmospheric pollution, food, cosmetics 
(Bagenstose et al., 1999; Bigazzi, 1998; Pelletier et al., 1994; Rowley & Monestier, 2005), 
dental amalgams (Eneström & Hultman, 1995; Guzzi et al., 2008; Pigatto & Guzzi, 2010), 
thimerosal-containing vaccines (Mutter & Yeter, 2008) and through the regular contacts with 
materials in manufacturing processes (da Costa et al., 2008). 
Mercury is one of the most global environmental pollutants, with human exposure to 
organic, inorganic, and elemental species of mercury occurring in many diverse settings. 
Relatively few studies exist in the literature on the relationship of mercury exposure and 
biomarkers of autoimmunity or autoimmune diseases in humans. Cases of mercury-induced 
autoimmune kidney disease mediated by immune complex (IC) deposition have been noted 
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historically in highly exposed populations (Gardner et al., 2010). A case-control study of 
scleroderma patients found an association between urinary mercury level and severity of 
the disease (Arnett et al., 1996). It is notable that the great artists who used paints containing 
mercury, suffered from autoimmune pathologies. Thus, P. Rubens, P.-A. Renoir, Robert O. 
Duffy suffered from rheumatoid arthritis, while P. Klee had systemic scleroderma (Pedersen 
& Permin, 1988). 
Anti-nuclear (ANA) and anti-nucleolar (ANoA) autoantibodies presence in serum are used 
in the clinical diagnosis of lupus and scleroderma (Ho & Reveille, 2003; Kurien & Scofield, 
2006), and some similarities have been noted between ANA/ANoA profiles in mercury-
induced autoimmunity (HgIA) models and in some patients with scleroderma (Takeuchi et 
al., 1995). The possible influence of mercury on the human population was confirmed by the 
results obtained from the experiments with people exposed by mercury on the gold mine 
sites in Amazonian Brazil (Silbergeld et al., 2005; Silva et al., 2004). Exposure to mercury in 
these populations is related to the use of mercury in riverine small-scale artisanal gold 
mining operations, in which miners are directly exposed to inorganic and elemental 
mercury, and downstream communities can be exposed by consumption of fish 
contaminated by methylmercury in impacted watersheds (Gardner et al., 2010). Exposure to 
either methyl or inorganic mercury in such populations is associated with elevated titers of 
detectable ANA and ANoA (Alves et al., 2006). 
Furthermore, through the use of rodent models, awareness of the direct effects of mercury 
on the immune system has increased. It is well known that the chronic administration of 
subtoxic doses of HgCl2 (mercuric chloride) induces a SLE-like autoimmune disease in 
genetically susceptible inbred mice with H-2s, H-2q, and H-2f haplotypes or their hybrids 
(Hansson & Abedi-Valugerdi, 2003; Hultman et al., 1999; Reuter et al., 1989; Roether et al., 
2002; Rowley & Monestier, 2005; Takeuchi et al., 1995). This HgIA is characterized by T-cell-
dependent polyclonal activation of B-lymphocytes (Abedi-Valugerdi, 2008; Johansson et al., 
1998), increased level of serum immunoglobulins (IgG1 and IgE) (Abedi-Valugerdi et al., 
2000, 2008), production of ANoA and by the formation of IC in different organs impaired 
their functions (Arefieva et al., 2010; Bagenstose et al., 1999; Eneström et al., 1984; 
Havarinasab et al., 2008; Hultman et al., 1989; Robinson et al., 1997). Female mice tend to be 
more susceptible to HgIA, consistent with sex differences observed in autoimmune diseases 
in humans (Fairweather et al., 2008). It is important to notice, that thimerosal (constituent 
part of some vaccines for human) is equipotent to inorganic mercury in eliciting a lupus-like 
immune response in susceptible animals, but mice treated with methylmercury do not 
develop renal or systemic IC deposition (Haggqvist et al., 2005; Havarinasab et al., 2005, 
2007; Havarinasab & Hultman, 2005). 
The interesting thing is that the nucleolar 34-kDa protein fibrillarin is the major 
autoantigen in such autoimmune disorders either in mice or in human. Fibrillarin is one 
of the most evolutionarily conserved proteins and is involved in the early stages of 
maturation of ribosomal RNA (rRNA). This protein can often be a target of autoantibodies 
in various autoimmune disorders (Ho & Reveille, 2003; Rhodes & Vyse, 2007; van 
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Eenennaam et al., 2002; Yang et al., 2003): systemic scleroderma (58% of cases), SLE (39% 
of cases), rheumatoid arthritis (60% of cases). The presence of autoantibodies to fibrillarin 
in patients' blood is a suitable diagnostic marker for the early stages of autoimmune 
diseases development (Tormey et al., 2001). In addition, a recent case-control study 
reported that severely affected scleroderma patients with anti-fibrillarin antibodies (AFA) 
were more likely to have higher levels of mercury in urine as compared either to less 
severely affected cases without AFA or controls suggesting an etiologic role for mercury 
in this autoimmune disease (Arnett et al., 2000). 
It is worth noting that, along with mercury which can induce the production of AFA among 
the genetically predisposed animals, some heavy metals such as silver (Abedi-Valugerdi, 
2008; Hansson & Abedi-Valugerdi, 2003; Suzuki et al., 2011) and gold (Havarinasab et al., 
2007, 2009) have the same ability. In addition, cadmium (Leffel et al., 2003), platinum (Chen 
et al., 2002) and lead (Tabata et al., 2003) are also known to have a negative impact on 
humans and animals. They induce/exacerbate the autoimmune processes in human and 
murine models of autoimmune diseases. However, unlike mercury, they do not cause such 
strong lymphoproliferation, polyclonal activation of lymphocytes and deposition of IC in 
kidneys - the most important features of autoimmune diseases. 
Taken all the foregoing into account, it becomes clear why HgIA in mice is used as a model 
of human systemic autoimmune disorders for testing of immunosuppressive agents and for 
investigating of the molecular mechanisms of heavy metal-induced autoimmunity. 
Following the modern hypothesis of a strong genetical predisposition to autoimmune 
diseases, the majority of animal experiments are conducted on inbred and genetically 
modified mice prone to mercury-induced or spontaneous autoimmunity. However, results 
obtained on such susceptible homozygous mice cannot be fully extrapolated on genetically 
heterogenous human population. That is why it is more correct to use different genetically 
heterogenous (outbred) mouse stocks as laboratory model in analysis of mercury exposure 
and consequences of it on humans. But, there are only a few studies supporting the idea that 
outbred mice are also susceptible to mercury and produce ANoA. It is earlier affirmed that 
development of ANoA production is controlled strictly by the class II of H-2 genes, i.e. only 
certain mouse strains with specific H-2 genotypes (e.g. H-2s and H-2q) produce ANoA upon 
exposure to mercury. Therefore, it was expected that mice carrying the heterozygous H-2 
genotype will be highly resistant to mercury-induced ANoA production. In controversial, it 
has been recently found that chronic treatment with mercury induces production of ANoA 
in a large number of outbred ICR, NMRI and Black Swiss mice (Abedi-Valugerdi, 2008). 
Regarding this matter Dr. Abedi-Valugerdi has spoken his hypothesis about the absence of 
the particular genetical susceptibility to HgIA. It means that unlike in inbred mouse strains, 
H-2 heterozygosity does not confer resistance to mercury-induced ANoA production. In 
other words, environmental factors can induce autoimmunity in the absence of specific 
susceptible genes in members of a genetically heterogenous population. Thus, it allows to 
use outbred mice as suitable model for research of HgIA. 
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As mentioned above, one of the most significant features of HgCl2-induced autoimmune 
process along with appearance of AFA is deposition of immune complexes in kidneys. It is 
necessary to notice that formation of IC in human kidneys is one of the consequences of 
heavy metals exposure or autoimmune diseases (Ohsawa, 1997; Markowitz & D'Agati, 
2009). However, the exact localization and composition of the IC in kidneys, mechanisms of 
its formation and possible cytotoxic effects still remain poorly understood. We have 
performed this work to elucidate these questions and in order to examine whether IC are 
present in other organs of inbred mice. Another goal of our study was to discover whether 
AFA production and IC deposition, which are typical for mercury-induced autoimmunity in 
H-2s and H-2q inbred mouse strains, could be reproduced in outbred mice. 
2. Material and methods 
2.1. Mice 
All studies presented were carried out in female inbred SJL/J and outbred CFW mice, which 
were 8 weeks old at the beginning of each experiment. Animals were obtained from Animal 
Breeding Facility-Branch of Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry 
(AAALAC accredited). All animals obtained were axenic at the time of arrival. The health 
status for these mice was confirmed by monitoring in the AnLab laboratory (Czech 
Republic). The mice were housed at the Animal Facilities of the Shemyakin-Ovchinnikov 
Institute of Bioorganic Chemistry of the Russian Academy of Sciences (Moscow, Russian 
Federation) under specific pathogen-free (SPF) conditions with access to tap water and 
standard chow ad libitum. All animal experiments described here were conducted in 
accordance with the "Good Laboratory Practice in Russian Federation" (Decree of the 
Minister of Health of RF #267, dated June 19, 2003), Section 11 of the Declaration of Helsinki 
of the World Medical Association (1964) and the International Guiding Principles for 
Biomedical Research Involving Animals (1985). 
2.2. HgCl2 treatment 
A solution of 0.4 mg/mL HgCl2 (Sigma-Aldrich, St. Louis, MO, USA) was prepared in sterile 
0.9% NaCl solution (OJSC Biochemist, Saransk, Russia). Groups of mice were injected 
subcutaneously (s.c.) with either 0.1 mL of HgCl2 (1.6 mg/kg body weight) or 0.1 mL of 
sterile 0.9% NaCl every third day for 6 weeks. 
2.3. Blood and tissue sampling 
Before the experiment and after 6 weeks of HgCl2 treatment, blood was obtained by retro-
orbital puncture under ether anesthesia. The collected blood was allowed to clot for 30 min 
at 37ºC, centrifuged (800g, 10 min) and the serum obtained was used or stored at -70ºC. 
Then, the mice were euthanized in a CO2 chamber. Their kidneys, liver and spleen were 
dissected out aseptically during the autopsy. The organ pieces were used for cryotomy or 
stored in liquid nitrogen until used. 
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2.4. Detection of anti-nucleolar antibodies 
The presence of serum ANoA was determined by indirect immunofluorescence (IIF) using 
murine NIH/3Т3 cells as a substrate. The cells were grown on glass coverslips in DMEM 
supplemented with 10% FCS, glutamine, penicillin, and streptomycin (Paneco, Moscow, 
Russia) at 37ºC in a 5% CO2 / 95% air atmosphere. Coverslips with attached cells were 
washed in PBS and fixed with 4% paraformaldehyde (PFA) in PBS for 15 min at room 
temperature, rinsed in PBS three times for 10 min, and permeabilized with 0.1% Triton X-
100 in PBS for 10 min on ice, then washed in PBS four times for 5 min. The cells were 
incubated with the primary antibodies (murine sera from autoimmune and control mice) 
diluted 1:100 to 1:10000 in PBS and kept in the dark in a moist chamber for 45 min. Then, the 
cells were washed in PBS three times for 10 min, and incubated with Cy2-conjugated goat 
anti-mouse immunoglobulin G (IgG) antibodies (Jackson ImmunoResearch Lab., West 
Grove, PA, USA), diluted 1:200, for 45 min under the same conditions. Control cells were 
processed at the same time and in the same way, except that PBS was used instead of the 
murine sera. No stained structures were seen in the controls. Then, the cells were washed 
again three times for 10 min, incubated in 1 μg/mL DAPI (4’,6’-diamidino-2’-phenyindole) 
(Sigma-Aldrich, St. Louis, MO, USA) solution at room temperature for 10 min and then 
mounted on slides with Mowiol containing DABCO (1,4-diazabicyclo[2.2.2]octane) (Sigma-
Aldrich, St. Louis, MO, USA). During the experimental period, slides were stored at 4ºC in 
the dark. The titer of ANoA was defined as the highest serum dilution that gave specific 
nucleolar staining (Havarinasab et al., 2008). 
The cells were examined using an Axiovert 200 epifluorescence microscope (Carl Zeiss, 
Oberkochen, Germany) with PlanNeoFluar 40×/NA 0.75, Fluar 100×/NA 1.25, and 
AchroPlan 100×/NA 1.3 objectives. Images were obtained using a 13-bit monochrome 
camera (CoolSnapcf; Roper Scientific, Tucson, AZ, USA). 
2.5. Analysis of immune complexes in kidneys 
The presence of renal IC in kidneys of inbred and outbred mice was detected by direct 
immunofluorescence (DIF). The slides with attached 5-μm thick cryosections (Microm HM 
525, ThermoFisher Scientific, Waltham, MA, USA) were washed in cold PBS and then air-
dried or fixed under various conditions: in absolute acetone/methanol for 5 min or in 4% 
PFA in PBS for 15 min. Some sections were then air-dried after fixation in absolute acetone 
or methanol. After incubation in 4% PFA, slides were washed three times for 10 min and 
permeabilized with 0.1% Triton X-100 in PBS for 10 min on ice, then washed in PBS four 
times for 5 min. After that, the sections were incubated with serial dilutions of either a 
fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse total Ig (IgG + IgA + IgM) 
antibodies (Imtek, Moscow, Russia) and/or rabbit anti-mouse complement factor C3 primary 
antibodies (Abcam, Cambridge, UK), diluted 1:10, and Texas Red-conjugated donkey anti-
rabbit IgG secondary antibodies (Jackson ImmunoResearch Lab, West Grove, PA, USA), 
diluted 1:400, in the dark in the moist chamber for 45 min. The initial dilution for FITC-
conjugated antibodies was 1:50. The end-point titer for total immunoglobulins (Ig) was 
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defined as the highest dilution that gave specific staining. Then, the slides were washed 
three times for 10 min, incubated in DAPI solution, as described above, and then mounted 
with Mowiol containing DABCO. During the experimental period, the slides were stored at 
4ºC in the dark. 
To visualize renal blood vessels varying in size and colocalize them with IC we used 
additional staining of organs with special dye Col-F (kindly furnished by Dr. Jerzy 
Dobrucki), which reveals collagen and elastin fibers that are part of the coats and elastic 
membranes of blood vessels. Halves of organs were washed in DMEM and put in Col-F dye 
solution in DMEM at 37ºC for 1 h. Then, the pieces of kidney were rapidly washed again, 
and cut for cryosections as described previously. To remove damaged/non-specifically 
stained tissue, the first 50-μm thick section was discarded. Fixed in 4% PFA cryosections 
were then washed and incubated according to the DIF method described above. 
With the aim of distinguishing between proximal and distal renal tubules and colocalizing 
them with IC, we performed a staining assay using phalloidin-tetramethylrhodamine B 
isothiocyanate (TRITC; Sigma-Aldrich, St. Louis, MO, USA). This is a fluorescent 
phallotoxin that can be used to detect actin-rich structures, such as the brush border of the 
proximal renal tubules. After fixation cryosections were incubated with a mix of 5 μg/mL 
TRITC-conjugated phalloidin solution and FITC-conjugated goat anti-mouse total Ig 
antibody in the dark in a moist chamber for 45 min, washed, incubated in DAPI and 
mounted with Mowiol. 
The slides were examined using Axiovert 200 epifluorescence and confocal LSM510 
microscopes (Carl Zeiss, Oberkochen, Germany). Images were obtained using a 13-bit 
monochrome camera (CoolSnapcf, Roper Scientific, Tucson, AZ, USA). 
2.5.1. Detection of immunoglobulin isotypes as components of renal IC 
Presence of IgG1, IgG2a and IgM immunoglobulins in kidneys of mercury-treated and 
control mice were determined using DIF, as described previously. To distinguish between 
IgG and IgM classes, we used fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse 
total Ig (IgG + IgA + IgM) antibodies (Imtek, Moscow, Russia) in combination with TRITC-
conjugated goat anti-mouse IgM secondary antibodies (Jackson ImmunoResearch Lab, West 
Grove, PA, USA). 
To evaluate the presence of IgG1 and IgG2a immunoglobulin isotypes, we used TRITC-
conjugated goat anti-mouse IgG antibodies (Jackson ImmunoResearch Lab, West Grove, PA, 
USA) in combination with FITC-conjugated goat anti-mouse IgG1 or IgG2a secondary 
antibodies (SouthernBiotech, Birmingham, AL, USA). The dilution for all the antibodies 
mentioned was 1:50. 
2.5.2. Glomerular cell death assessment 
The terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) method 
was performed on the kidney cryosections to visualize apoptotic glomerular cells to assess 
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the cytotoxicity of immune deposits. It is widely known that the most common biochemical 
property of apoptosis is the endonucleolytic cleavage of chromatin. This method identifies 
apoptotic cells in situ using terminal deoxynucleotidyl transferase (TdT) to transfer biotin-
dUTP to the free 3’-OH of cleaved DNA. The biotin-labeled cleavage sites were then 
visualized by reaction with fluorescein-conjugated avidin (avidin-FITC). TUNEL staining 
was conducted with a kit (TUNEL Apoptosis Detection Kit, Upstate Biotechnology, Lake 
Placid, NY, USA) according to the manufacturer’s protocol. Next, the slides were incubated 
in DAPI solution, then mounted with Mowiol containing DABCO. The cells were then 
observed using a fluorescence microscope. Sections treated with 1 μg/mL bovine DNase I 
were used as a positive control for the TUNEL assay and DNA fragmentation. 
2.6. Analysis of immune complexes in liver and spleen 
The presence of IC in liver and spleen of inbred and outbred mice was also detected by DIF. 
The slides with attached cryosections were washed in cold PBS and then fixed in 4% PFA in 
PBS for 15 min. After that, the slides were prepared as described above.  
For the blood vessels detection we used the same technique as it was described for kidneys.  
2.7. Assay for in vivo binding of mercury-induced ANoA to the nucleoli of living 
cells 
The colocalization of the mercury-induced ANoA with nucleolar protein fibrillarin within 
the cell nucleoli in mercury-treated outbred mice was detected by the IIF method. Briefly, 
the sections were fixed in 4% PFA, washed, permeabilized and incubated with 1:50 dilution 
of the primary rabbit polyclonal anti-fibrillarin antibodies (Abcam, Cambridge, UK) in the 
dark in the moist chamber for 45 min and washed again. FITC-conjugated goat anti-mouse 
total Ig (IgG + IgA + IgM) antibodies (Imtek, Moscow, Russia) in combination with Texas 
Red-conjugated donkey anti-rabbit IgG secondary antibodies (Jackson ImmunoResearch 
Lab, West Grove, PA, USA), diluted 1:100 and 1:200 respectively, were used as secondary 
antibodies. Then the slides were washed again, stained with DAPI and mounted with 
Mowiol according the IIF technique. 
2.8. Statistical analysis 
Serum levels of ANoA and IC titers are all expressed as means±standard deviation. 
Differences between these parameters for the control and Hg-treated groups were analyzed 
for statistical significance using the Mann-Whitney U-test. P values < 0.05 were considered 
to indicate statistical significance. 
3. Results 
3.1. HgCl2 induces ANoA production in inbred and outbred mice 
To test the ability of mercury to induce ANoA production in inbred and outbred mice, sera 
obtained from experimental and control mice were tested using an IIF technique. Analysis of 
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sera obtained from mice at the end of the experiment (after 6 weeks of HgCl2 treatment) showed 
that mercury was able to induce ANoA, in contrast to the saline-injected controls. The mean 
titer of ANoA in group of mercury-treated inbred mice was about 1520, in group of outbred 
mice - 10545 (Table 1). The pre-bleed sera from all groups of animals were ANoA-negative. 
 
Mouse 
stock 
Treatment
No. of 
mice 
Titer of 
ANoA 
Titer of IC 
Glomerular 
mesangium
Blood vessel 
walls
Proximal 
tubules 
Inbred 
SJL/J 
6 weeks of 
HgCl2
5 1520±17721,2 17600±78382 14400±32002 40002 
6 weeks of 
NaCl
4 0 1400±400 0 1400±400 
Outbred 
CFW 
6 weeks of 
HgCl2
12 10545±32362 6083±20182 4750±18682 13167±84622 
6 weeks of 
NaCl
12 0 1700±249 0 2000±1083 
1 The numbers refer to mean reciprocal titer ± standard deviation; 2 P < 0.05, vs. saline-treated controls (Mann-Whitney 
U-test). 
Table 1. Titers of serum ANoA and IC in kidneys of autoimmune and control mice. 
Sera were incubated on NIH/3T3 cells followed by incubation with FITC-conjugated anti-
mouse immunoglobulin antibodies; they characteristically stained nucleoli of interphase 
cells and peripheral chromosomal material (PCM) in mitotic cells (Fig. 1). Such stained 
regions matched the areas in which the major autoantigen in HgIA, fibrillarin, was revealed. 
 
Figure 1. The nucleolar protein fibrillarin in murine NIH/3T3 cells is identified by serum from SJL/J 
autoimmune mouse treated with HgCl2. A - indirect immunocytochemistry reveals fibrillarin in the 
nucleoli of interphase cells (arrows) and in the peripheral chromosomal material of metaphase cells 
(insert); sera from CFW autoimmune mice reveal the same staining patterns. B - DAPI staining of 
interphase nuclei and metaphase chromosomes. Scale bar - 10 μm. 
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So, we have concluded that six weeks of HgCl2 treatment to female SJL/J and CFW mice 
resulted in strong ANoA production. 
3.2. HgCl2 induces heavy immune complex deposition in kidneys of inbred and 
outbred mice 
3.2.1. Identification of glomerular IC in murine kidneys 
Glomerular IC were revealed with all variants of tissue treatment (Table 2). However, on 
fixed cryosections, the general tissue morphology was better than on unfixed sections. In all 
cases, immune deposits were seen in the form of granules, which in places with the highest 
congestion merged and looked like brightly fluorescing spots (Fig. 2). Under epifluorescence 
and confocal microscopes, immune deposits often repeated the form of the mesangial cells 
and were clearly visible in the plane of the nuclei, as revealed using the dye DAPI or phase 
contrast (Fig. 2, 3). Additionally, only fixing with 4% paraformaldehyde strongly reduced 
the background fluorescence and increased clarity when looking at a tissue; the borders of 
the immune deposits appeared to be much sharper than with the other fixing techniques. 
Additionally, fixed sections could be stored for about 3 months at -70ºC without any 
appreciable loss of staining ability. 
 
Localization 
Type of fixation
Air-drying Acetone 
Acetone/ 
air-drying
Methanol 
Methanol/ 
air-drying 
4% PFA 
Glomerular 
mesangium 
+1 + + + + + 
Blood vessel walls + + + + + + 
Proximal tubules -2 - - - - + 
1 Presence of IC; 2 absence of IC. 
Table 2. IC in kidneys of HgCl2-treated mice, revealed with various fixing conditions. 
Our results showed a significantly increased titer of immunoglobulins in the glomerular 
mesangium in kidneys of HgCl2-treated animals compared with control mice (Table 1). The 
HgCl2-treated groups of mice showed a mean titer of mesangial Ig of about 17600 (inbred 
mice) and 6083 (outbred mice). The saline-injected control groups showed only 1400 
(inbred) and 1700 (outbred) mean titers of secondary antibodies. 
Moreover, we also have found the deposition of C3 component of complement system as 
part of glomerular IC (Fig. 4). It is necessary to notice that such С3 deposits do not always 
colocalize with regions containing immunoglobulins. This means that there are such areas in 
glomeruli where only C3 is revealed, but at the same time immunoglobulins are not seen. 
The saline-injected control mice were completely devoid of С3 deposits. 
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Figure 2. Immunohistochemical detection of immunoglobulins in glomeruli of autoimmune inbred (A-C) 
and outbred (D-F) mice. Left column - phase contrast, middle column - total immunoglobulin staining, right 
column - merge of immunoglobulin staining and nuclear chromatin DAPI–staining. Arrows point to 
glomerular cells in which it can be clearly seen that immunoglobulins are located in the cytoplasm around 
the cell nucleus. Immunoglobulins in the nuclei of outbred mice are also clearly seen. Scale bar - 30 μm. 
 
Figure 3. Visualization of immunoglobulins in glomerulus of autoimmune mouse under confocal laser 
scanning microscope. A–E: glomerular area reconstructed on the base of serial optical sections (counter-
clockwise rotation model); F: side-view of the reconstructed area (thickness of this area is about 7 μm). 
Scale bar - 30 μm. 
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Figure 4. Localization of immunoglobulins and the C3 component of the complement system as 
components of immune deposits in glomerulus of autoimmune mouse after HgCl2 treatment. A - phase 
contrast, B - total immunoglobulin staining, C - staining of C3 component of the complement system. 
Arrows show the C3-containing areas without immunoglobulins. Scale bar - 30 μm. 
3.2.2. Identification of vascular IC in murine kidneys 
Additionally, only the mercury-treated mice, not the control groups (Table 1), showed IC (Ig 
+ C3) in the walls of renal blood vessels with all variants of tissue treatment (Table 2). This 
finding was confirmed by colocalization of IC with collagen and elastin fibers that are part 
of the coats and elastic membranes of blood vessels, which we revealed using the Col-F dye 
(Fig. 5). Comparison of places with immune deposit localization with collagen and elastin 
staining allowed us to conclude that IC were present in both the endothelial zone of vessels 
and in different layers of the basement of the vessel walls. Using the Col-F dye allowed us to 
conclude that deposits were present in all renal vessel walls, regardless of their size. 
Moreover, Col-F revealed even vessels that were not seen clearly with phase contrast. 
Similarly, glomerular IC could be seen in the form of granules, which in places with the 
highest concentration merged and looked like brightly fluorescing spots.  
The mean titer of vascular Ig in the kidneys of the HgCl2-treated groups of mice reached 
14400 (inbred mice) and 4750 (outbred mice). The saline-injected control groups were 
completely devoid of deposits (Table 1). 
3.2.3. Identification of tubular IC in murine kidneys 
Immune deposits in renal tubules were seen out only when using 4% PFA as a fixative 
(Table 2). IC were seen in discrete granules of approximately equal size (about 1 μm) located 
in tubular epithelial cells (Fig. 6B, C).  
We note that part of the renal tubules contained immune deposits whereas another part had 
none. To determine in which type(s) of renal tubules IC were present, we performed a 
combination of IHC analysis and staining with phalloidin-TRITC. As is well-known, 
phalloidin binds to actin, the basic structural component of the brush border, which is 
present in proximal renal tubules and is not expressed in distal parts. These results suggest 
that immune deposits were seen only in the proximal renal tubules, with a brush border, 
and not in the distal tubules, without a brush border (Fig. 6A, B). 
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Interestingly, the tubular IC consisted of immunoglobulins, but not the C3 component of 
complement. The mean titer of such deposits in proximal tubules was nearby 4000 (inbred) 
and 13167 (outbred). Besides, elevated titer of IC in the proximal tubules in outbred mice 
(compared with inbred mice) correlated with elevated titer of ANoA in their blood. 
Furthermore, the control group exhibited a lower mean titer of IC - 1400 for inbred mice and 
2000 for outbred mice (Table 1). To our knowledge, this is the first report of immune 
deposits in the proximal renal tubules. 
 
Figure 5. Immunoglobulins in renal blood vessels of varying sizes in autoimmune mice revealed with 
Col-F - a dye specific for collagen and elastic fibers. A, B - immunoglobulins in the blood vessel, which 
is clearly seen under phase contrast: A - phase contrast, B - staining with antiimmunoglobulin 
antibodies (red), Col-F dye (green) and nuclear chromatin staining with DAPI (blue); inserts, arrows - 
immunoglobulins in the endothelial part of this vessel. C, D - immunoglobulins in the blood vessel, 
revealed only by the Col-F dye: C - Col-F dye, D - staining with anti-immunoglobulin antibodies (red) 
and Col-F dye (green). Scale bar - 50 μm. 
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Figure 6. Localization of immunoglobulins in proximal renal tubules in inbred (A, B) and outbred (C) 
mice. A - revealing of brush border (arrows) in proximal tubules of inbred mice with the help of 
Phalloidin-TRITC staining, B - revealing of immunoglobulins in cytoplasm of epithelial cells in 
proximal tubules (arrows) of inbred mice; scale bar - 30 μм. C - revealing of immunoglobulins in 
cytoplasm and nuclei (arrows) of epithelial cells in outbred mice; scale bar - 20 μm. 
3.2.4. Identification of immunoglobulin isotypes as components of IC in kidneys of inbred 
and outbred mice after HgCl2 treatment 
To understand which classes and isotypes of immunoglobulins are found in IC in different 
parts of murine kidneys, we performed combined multicolor DIF. Our results showed that 
immunoglobulin class G (IgG) occurred in all locations of IC: in glomeruli, blood vessel 
walls, and proximal tubules of autoimmune mice, and in glomeruli and proximal tubules of 
control mice. Immunoglobulin class M (IgM) was seen in glomeruli, proximal tubules, 
vessel walls of outbred autoimmune mice, and only in the glomeruli of both inbred 
autoimmune and control mice (Table 3). We did not assess whether immunoglobulin class A 
(IgA) was part of the immune complexes. 
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Mouse 
stock 
Localization 
IgG + IgM + 
IgA 
IgG1 IgG2a IgM 
control HgCl2 control HgCl2 control HgCl2 control HgCl2 
In
b
re
d
 S
JL
/J
 
Glomerular 
mesangium 
+1 + + + -2 ±3 + + 
Blood vessel 
walls 
- + - + - - - - 
Proximal 
tubules 
+ + + + - + - - 
Nucleoli - - - - - - - - 
O
u
tb
re
d
 C
F
W
 
Glomerular 
mesangium 
± + ± + - - ± + 
Blood vessel 
walls 
- + - + - - - ± 
Proximal 
tubules 
+ + ± + - ± - + 
Nucleoli - + - + - + - - 
1 Presence of IC; 2 absence of IC; 3 slight deposits. 
Table 3. Occurrence of different immunoglobulin isotypes as components of IC in kidneys of 
autoimmune and control mice. 
Next, we tried to determine the IgG isotypes in IC. The results showed that the mesangial 
IgG deposits were dominated by the IgG1 isotype, but also contained IgG2a, consistent with 
Havarinasab et al. (2008). At the same time, we found only the IgG1 isotype in renal vessel 
wall deposits and both IgG1 and IgG2a isotypes in proximal tubule deposits (Table 3). The 
saline-injected control mice showed an absence of IgG2a deposits. 
3.2.5. Assessment of possible IC toxicity in murine kidneys 
To analyze the possible cytotoxicity of renal IC, we used the TUNEL method, which reveals 
fragmentation of DNA, a sign of cell destruction, in situ. The results showed that in 
glomeruli of both experimental and control animal groups, there was no significant increase 
in TUNEL-positive (i.e., apoptotic) cells. 
3.3. Identification of IC in liver and spleen of inbred and outbred mice after 
HgCl2 treatment 
In the liver, a granular fixation of the anti-Ig antibodies was observed in the blood vessel walls 
of mercury-treated mice and, in contrast with earlier studies, in the liver hepatocytes in all 
groups of mice (Fig. 7). As in the kidneys, our results showed a significantly increased titer of 
Ig in the hepatocytes of HgCl2-treated animals compared with control mice (not shown). 
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In the spleen, an intense granular pattern of the anti-Ig antibodies fixation was observed in 
the blood vessel walls and in the cells of lymphoid follicles, germinal centers, marginal 
zones and periarterial lymphatic sheaths (PALS) in mercury-treated mice (Fig. 8A, B).  
White pulp of control animals had very rare and small germinal centers (these centers are 
known to appear during the Th2-dependent immune reactions). In contrast, germinal 
centers after the mercury chloride treatment were enlarged, prominent and quite frequent in 
all mice. Therefore, clear morphological attributes of Th2-antibody-producing immune 
response had been induced by the mercury chloride treatment in spleen. 
 
 
 
 
 
Figure 7. Immunohistochemical detection of immunoglobulins in liver of autoimmune inbred (A-B) 
and outbred (C-D) mice. A, C - immunoglobulins in liver blood vessels (total immunoglobulin staining); 
B, D - immunoglobulins in hepatocytes (merge of immunoglobulin staining and nuclear chromatin 
DAPI–staining), arrows point to nuclei in which immunoglobulins can be clearly seen. Scale bar - 20 μm. 
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Figure 8. Immunohistochemical detection of immunoglobulins in spleen of autoimmune inbred (A) and 
outbred (B-E) mice. A, B - immunoglobulins in spleen blood vessels (A-central artery, arrows) and white 
pulp (F-follicle, G-germinal center, P-PALS), scale bar - 50 μm. C-E - results of colocalizing procedure: C - 
total immunoglobulin staining, D - staining with antifibrillarin antibodies, E - merge of 
immunoglobulin and fibrillarin staining patterns (yellow - arrows), scale bar - 20 μm. 
3.4. Mercury-induced ANoA bind to the nucleoli of the kidney, liver and spleen 
cells in outbred mice in vivo 
After analyzing the organs such as kidney, liver and spleen in all animals after 6 weeks of 
HgCl2 treatment, we noticed some differences in the staining patterns in tissues from inbred 
and outbred mice following the method of DIF. As shown in Fig. 2, 6, 7, 8 most of the cells in 
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the kidney, liver and spleen sections of mercury-treated outbred mice exhibited a strong 
nucleolar staining pattern with high titers of IgG1 and IgG2a immunoglobulins (Table 3). A 
nucleolar green fluorescence was found in the cells of the tissue sections prepared from the 
mercury- but not saline-injected mice. It should be noted that such intranucleolar staining 
was absent in nucleoli of inbred mercury-treated mice. 
In a purpose of better understanding of autoantigen specificity, we colocalized such 
nucleolar patterns recognized by FITC- conjugated anti-Ig antibodies with loci recognized 
by commercial antibodies to nucleolar protein fibrillarin. The colocalizing procedure 
showed the whole coincidence of regions containing immunoglobulins with sites of 
nucleolar protein fibrillarin localization (Fig. 8C, D, E), allowing us to offer the hypothesis 
about different capability of autoantibodies to penetrate the cells in inbred and outbred mice 
after HgCl2 treatment. 
These results demonstrate for the first time that injection of mercury into the genetically 
geterogenous outbred mice induced autoantibodies which are able to penetrate into the cells 
of certain organs and react with their corresponding nucleolar antigens in vivo.  
4. Discussion 
The main hallmark of mercury-induced autoimmunity in genetically susceptible mice is the 
production of ANoA against the 34 kDa nucleolar protein fibrillarin (Abedi-Valugerdi, 
2008). Because lots of studies have demonstrated that only homozygous mouse strains with 
susceptible H-2 genotypes are able to produce ANoA after mercury treatment, we next 
performed this work to test the ability of such heavy metal to induce ANoA production and 
IC deposition in heterozygous mouse population.  
As demonstrated in Table 1 , 6 weeks of HgCl2 treatment induced the ANoA production in 
both inbred and outbred mice in variable titers, whereas control saline-treated mice did not 
show any ANoA production. Moreover, it should be noted that magnitude of mercury-
induced ANoA in outbred mice was even higher than that induced in inbred mice.  
Another characteristic feature of HgIA we tested was the deposition of immune complexes 
in the kidney. According to literature reports, revealing IC in different parts of the kidney in 
autoimmune animals is usually done in two basic ways: on air-dried and acetone-fixed 
cryosections or on formaldehyde-fixed and paraffin-embedded sections (Chowdhury et al., 
2005; Gobe & Nikolic-Paterson, 2005). Each of these procedures has its own advantages and 
disadvantages. Immunofluorescence (IF) staining of renal biopsies for the deposition of 
immunoglobulins and complement components is often the primary approach for a 
differential diagnosis of glomerular disease. However, a limitation of such IF applications is 
that they require frozen sections, which can suffer a loss of structural integrity during the 
process of tissue freezing (Gobe & Nikolic-Paterson, 2005). On the other hand, the problem 
with formaldehyde-fixed and paraffin-embedded sections is that tissue antigens are often 
denatured or masked (Chowdhury et al., 2005). 
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Thus, in the present work we tried to combine these approaches by fixing renal cryosections 
with formaldehyde under standard conditions along with routine clinical air-drying or 
acetone-fixing. This allowed us to use the highly informative IF method.  
We showed that treatment of the cryosections with organic fixatives (acetone and methanol) 
led to appreciable damage of the renal tissue, but did not interfere with revealing IC in 
kidneys. These observations correlate well with scanning electron microscopy data, which 
showed damage to the plasma membrane of cells by fixing with acetone and methanol 
(Hoetelmans et al., 2001). We do not favor the air-drying of sections; despite its simplicity, 
preservation of cells on such cryosections was poor. Thus, the best choice of fixative for cell 
preservation was paraformaldehyde; it also appeared to be best in the context of 
information in that using it, we found out IC in renal proximal tubules in kidneys in all 
groups of mice. To our knowledge, there is no previous report on the presence of IC in 
proximal renal tubes. 
In view of the fact that treatment with the organic fixatives leads to dehydration of the 
tissue, removing many water-soluble intracellular proteins, we suggest that the IC in 
proximal renal tubules consist largely of water-soluble complexes. Further, it does not seem 
strange that only the proximal tubules contained IC, while the distal tubules lacked them. It 
is known that molecules as big as immunoglobulins can be reabsorbed only in the proximal 
tubules, while the main function of the distal parts of the nephron is reabsorbtion of 
electrolytes. 
In contrast to deposits in proximal renal tubules, glomerular IC in kidneys of autoimmune 
animals have been mentioned in the literature many times (Abedi-Valugerdi et al., 1997; 
Bigazzi, 1999; Havarinasab et al., 2008; Hultman et al., 1987, 1992, 1993; Kono et al., 2001). 
However, there is a question as to where (in mesangial cells and/or on their surface) they are 
located. Our results, merging areas with IC and DAPI staining by epifluorescence and 
confocal microscopy, suggest that, at least, the major part of deposits is localized inside the 
cells. Nevertheless, we cannot exclude the possibility that some part of the deposits is 
situated on the cell surface. For a definitive conclusion about the localization of glomerular 
IC, a study using electron IHC is necessary. 
In addition to renal IC, we have found immune deposits in increased titers in liver 
hepatocytes and the white pulp spleen cells, suggesting in favor that HgIA is a 
comprehensive process involving many organs. 
Furthermore, the development of HgIA is accompanied by the occurrence of IC in blood 
vessel walls (Hultman et al., 1993). It was recently shown that the dye Col-F binds 
selectively with the collagen and elastin fibrils in coats and elastic membranes of blood 
vessels in native tissues. However, the possibility of using Col-F in combination with the 
IHC analysis has not been reported previously. Thus, an original protocol for the 
simultaneous staining of collagen and elastin fibrils and immunolabeling of immune 
deposits was developed. Our observations, based on specific staining of collagen and elastic 
fibers as a part of vessel walls with the dye Col-F, allowed us to localize the IC in both the 
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endothelial zone and across the whole width of the vessel walls in kidney, liver and spleen 
of mercury-treated mice. Additionally, revealing fibers using Col-F allowed us to visualize 
even the small vessels that were poorly identified with phase contrast because of elastic 
membrane thinning and luminal occlusion after tissue freezing. 
According to our results, IC were present not only in organs of autoimmune mice, but also 
in the glomeruli, renal proximal tubules, hepatocytes and in the cells of spleen lymphoid 
follicles of control animals, although at a much lower level. This does not seem strange, 
because it is well-known in medicine that autoantibodies are found not only in the blood of 
autoimmune patients, but also in healthy individuals. In particular, sera from healthy 
people are capable of staining different cells (e.g., Hep-2) in an IIF reaction (Koelsch et al., 
2007). However, the concentration (titer) of such antibodies is at least an order of magnitude 
less than in autoimmune patients. So, it seems possible that such antibodies in renal 
glomeruli, hepatocytes and proximal tubules could be derived from blood by filtration and 
primary urine by reabsorbtion, respectively, and become deposited in the cells. And the 
presence of immunoglobulins in cells of lymphoid follicles in the spleen is a sign of the 
normal functioning of the immune system. 
Our investigation shows that immune complex deposits can differ not only in quantity, but 
also in composition. The C3 component of the complement system was seen as part of the 
renal IC only in the glomeruli and blood vessel walls, but not in the proximal tubules. In 
contrast with earlier studies (Hultman et al., 1987), the present investigation showed that 
some areas of the glomeruli containing С3 lacked Ig. Reasons for these features of IC 
composition can be a subject of future research. For these purposes, use of a laser 
microdissector with subsequent mass-spectrometric analysis of the cut areas may be useful. 
Moreover, as described in the Results, renal IC consist of not only different classes but also 
different immunoglobulin isotypes. We demonstrated that glomerular IC include IgG, IgM, 
and, possibly, IgA immunoglobulins, while the vessel wall and proximal tubules contain 
almost no IgM. 
More interesting is the occurrence of IgG immunoglobulin isotypes in the immune 
complexes. Results from initial studies suggested that HgIA in mice is mediated by a T 
helper type 2 (Th2) response (i.e., polyclonal B cell activation with hyper-IgE and -IgG1 
production) (Abedi-Valugerdi, 2008; Gillespie et al,. 1995, 1996; Goldman et al., 1991; Ochel 
et al., 1991). However, further studies have revealed that the development of mercury-
induced autoimmune manifestations cannot be explained simply by Th2-based immune 
response (Abedi-Valugerdi, 2008). In particular, IFN-ɣ, a key cytokine produced by 
activated T helper type 1 (Th1) cells, induces IgG2a response in the mouse and is absolutely 
required for the induction of ANoA production in this autoimmune condition (Abedi-
Valugerdi 2008; Kono et al., 1998). Our results are consistent with this. Despite the Th2-
dependent appearing of germinal centers in spleen after HgCl2-treatment and the 
prevalence of the Th2-mediated IgG1 isotype as a component of IC, we also saw some IgG2a 
in the deposits, arguing in favor of Th1 activation too. 
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With all that the most important result of our research is the discovery of the ability of 
HgCl2-induced ANoA to transverse the plasma and nuclear membrane of living cells and 
translocate to the nucleoli of different cells in outbred mice in vivo. We found that mercury-
induced ANoA penetrated into the cells of certain organs (kidney, liver and spleen) and 
colocalized with special nucleolar protein fibrillarin - the major autoantigen in HgIA. This 
fact once again place outbred mice in close quarters with humans. As is well known from 
the literature, the autoantibodies from SLE patients are able to penetrate into the nuclei of 
cells in certain organs (Foster et al., 1994; Vlahakos et al., 1992; Yanase et al., 1997; Zack et 
al., 1996). It is likely that mercury-induced ANoA contain basic amino acid-rich sequences 
similar to those seen in anti-DNA autoantibodies derived from lupus-prone mice, allowing 
them to penetrate into the cell nuclei (Abedi-Valugerdi et al., 1999). Several studies have 
shown that penetrating autoantibodies cause cellular dysfunction after entering the cell and 
reacting with their intracellular antigens (Abedi-Valugerdi et al., 1999; Koscec et al., 1997; 
Reichlin, 1995). Therefore, it has been suggested that these antibodies might have 
pathogenic roles. However, our results do not confirm this, at least, at the beginning of the 
development of such mercury-induced autoimmune response. Formation of IC in different 
parts of the kidney was not accompanied by visible destruction or cell death, at least as 
evidenced by the TUNEL assay. The article of Abedi-Valugerdi et al. (1999) offers two 
possible explanations of this fact. First of all, the main target for mercury-induced ANoA is 
fibrillarin, which is known to be associated with snRNAs. In mammals the exact function of 
fibrillarin is not known, but it has been suggested that this nucleolar protein possibly 
participates in ribosomal biosynthesis. Based on this suggestion, it is likely that fibrillarin 
does not have a crucial role in the DNA synthesis and interfering with its function/structure 
by ANoA would not impair the cell proliferation. Second, since besides fibrillarin, several 
other nucleolar proteins (nucleolin, Surf-6, etc.) are also present in the mammalian nucleoli, 
it is likely that if fibrillarin is required for DNA synthesis and if binding of ANoA to 
fibrillarin impairs it’s function, other nucleoproteins will take over fibrillarin’s function. 
Since it has been suggested that fibrillarin is involved in the synthesis of ribosomal RNA, 
further studies are needed to test if nucleolar localization of ANoA would affect other cell 
functions such as protein synthesis. But, nevertheless, we cannot exclude the third 
possibility that destructive alterations could appear in later stages of disease development, 
because it is known that renal failure is one of the negative features associated with human 
autoimmune diseases (Tormey et al., 2001). 
5. Conclusion 
Thus, in our work we have shown that HgCl2 induce very strong autoimmune process both 
in inbred and outbred mice, accompanied by ANoA production and heavy IC deposition. 
We have described novel localization and composition of such immune deposits in different 
organs. Also, we have come to conclusion about the higher penetrating capability of 
autoantibodies in outbred mice as compared with inbred mice. So, we have discovered that 
genetically heterogenous outbred CFW mice produce the same reaction on standard HgCl2 
treatment (1.6 mg/kg twice a week) as inbred SJL/J mice previously described to be most 
susceptible.  
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Our data thoroughly confirm and continue the findings of Dr. Abedi-Valugerdi suggesting 
that certain environmental factors, without requiring the presence of specific susceptibility 
genes, can induce some autoimmune manifestations in members of a genetically 
heterogenous population. 
We think that outbred mice with HgCl2-induced autoimmunity may also be used for testing 
of immunosuppressive drugs because they better reflect the human population then 
homozygous inbred mice. Thus, the present study could be very useful for further 
understanding, prediction and therapy of human systemic autoimmune diseases, in 
particular developing after the regular exposure of mercury compounds. 
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